Hepatitis C Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hepatitis C Tests Market Report Overview
The Hepatitis C tests market size was valued at $1.77 billion in 2023 and will register a negative CAGR of less than 1% during 2023-2033.
Hepatitis C virus (HCV) is an RNA virus belonging to the Flaviviridae family that can cause chronic hepatitis and cirrhosis. Test kits for HCV detection are used to identify HCV carriers, who may remain asymptomatic for many years.
Hepatitis C Tests Market Outlook 2023-2033 ($ Billion)
Buy the Full Report for More Insights on the Hepatitis C Tests Market Forecast, Download a Free Sample Report
The Hepatitis C tests market research report identifies quantitative market trends within in vitro diagnostics therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also provides an in-depth discussion of COVID-19’s effects on the Hepatitis C tests market for 2020 and beyond. Furthermore, the report provides Hepatitis C tests market share by company that will help in identifying untapped market opportunities.
Market Size (2023) | $1.77 billion |
CAGR (2023-2033) | >(1)% |
Historic Period | 2015-2022 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Hepatitis C Tests Market Segments
The key segments in the Hepatitis C tests market are Hepatitis Tests and Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests (NAATs). The sub-categories of this market are Hepatitis C Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests and Hepatitis C Nucleic Acid Amplification Tests (NAATs). In 2023, Hepatitis Tests led the market.
Hepatitis Test Kits are used to detect or diagnose Hepatitis virus, a group of viruses that can cause liver inflammation, leading to liver failure and potentially liver cancer. The Hepatitis Test Kits market includes the sub-segments Hepatitis B Tests and Hepatitis C Tests.
Hepatitis C Nucleic Acid Amplification Tests (NAATs) involve the amplification of specific nucleic acid sequences of the Hepatitis C virus by targeting RNA. The process involves a polymerase chain reaction or ligase chain reaction with specific primers.
Hepatitis C Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights into the Hepatitis C Tests Market Segments, Download a Free Sample Report
Hepatitis C Tests Market Segmentation by Regions
The key regions in the Hepatitis C tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, the North American Hepatitis C tests market was the leading regional segment.
Strong growth is expected to occur in the North American Hepatitis C tests market over the next decade. The US and Canadian markets are both expected to grow, while a slight decline is expected in the Mexican market. The number of Hepatitis C tests performed for prevalent cases is expected to increase in all three North American countries, with the number of suspected infection cases also expected to increase in the US and Mexico.
The growth in these economies is also attributed to the increases in source plasma and whole blood donations, respectively. The number of pregnant women in these two countries is also expected to increase, further augmenting the Hepatitis C tests market.
Hepatitis C Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Hepatitis C Tests Market, Download a Free Sample Report
Hepatitis C Tests Market – Competitive Landscape
In 2023, Quidelortho Corp Hepatitis C tests market share was the highest
The key companies in the Hepatitis C tests market are:
- Abbott Laboratories
- Hologic Inc
- Quidelortho Corp
- Oswaldo Cruz Foundation
- Grifols SA
Companies may wish to invest in a communication campaign to facilitate education about Hepatitis C among healthcare providers, local partners, and patients, ideally using multilingual campaign materials as a competitive strategy.
Companies may want to fund training and education initiatives to increase physician familiarity with their brand or type of device. In nations with the capacity to adopt more thorough screening programs, these initiatives can also help raise awareness of hepatitis C disease.
Hepatitis C Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Hepatitis C Tests Market, Download a Free Sample Report
Hepatitis C Tests Market Dynamics
Trends: The incidence of HCV is expected to remain stable in most countries during the forecast period. However, HCV incidence is expected to increase in the US, Canada, China, and Brazil, while incidence is decreasing in Germany, Australia, and New Zealand. Screening of pregnant women for HCV is the standard of care in most countries. This strategy is considered cost-effective for reducing the risk of transmission to the baby. All HCV antibody-positive pregnant women should undergo HCV RNA testing at the start of prenatal care. Routine liver function tests are also recommended for these women to assess the risk of mother-to-child transmission and the extent of their liver disease.
Future Outlook: During the COVID-19 Pandemic: Social distancing measures and irregular hospital services have caused HCV screening to reduce significantly. This reduction in screening may lead to later stage diagnoses of HCV, which could be fatal for patients. In each country, HCV test sales are influenced by a variety of different factors including fluctuations in disease incidence and prevalence, the number of pregnant women, sperm donations, whole blood donations, and source plasma donations.
Buy the Full Report for Additional Hepatitis C Tests Market Dynamics, Download a Free Sample Report
Segments Covered in this Report.
Hepatitis C Tests Segment Outlook ($Billion, 2015-2033)
- Hepatitis Tests
- Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests (NAATs)
Hepatitis C Tests Regional Outlook ($Billion, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
The Hepatitis C tests market research report includes an insightful review of the key industry trends.
- The Hepatitis C tests market report offers annualized market revenue details by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global Hepatitis C tests market insights:
- The Hepatitis C tests market share report offers qualitative insights into global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Hepatitis C tests market SWOT analysis.
- The report provides trends and Hepatitis C tests market competitive dynamics.
Buy the Full Report for More Insights into the Hepatitis C Tests Market Share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources, including databases of government procedures and hospital purchasing.
Companies covered: Abbott Laboratories, Grifols SA, F. Hoffmann-La Roche Ltd, QuidelOrtho Corp, Hologic Inc, Oswaldo Cruz Foundation, Siemens AG, Qiagen NV, DiaSorin SpA, and others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the Hepatitis C tests market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the Hepatitis C tests market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on colorectal cancer.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving colorectal cancer.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of Hepatitis C tests market share by company. Identify strong competitors and create winning strategies to stand out in the global Hepatitis C tests market.
- Track regional Hepatitis C tests market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global Hepatitis C tests market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
Grifols SA
F. Hoffmann-La Roche Ltd
QuidelOrtho Corp
Hologic Inc
Oswaldo Cruz Foundation
Qiagen NV
DiaSorin SpA
Siemens Healthineers AG
Frequently asked questions
-
What was the Hepatitis C tests market size in 2023?
The Hepatitis C tests market size was $1.77 billion in 2023.
-
What will the Hepatitis C tests market CAGR be during 2023-2033?
The Hepatitis C tests will register a negative CAGR of less than 1% during 2023-2033.
-
Which was the leading segment in the Hepatitis C tests market in 2023?
The Hepatitis Tests segment was leading the Hepatitis C tests market in 2023.
-
Which region held the largest share of the Hepatitis C tests market in 2023?
North America was the largest regional market for Hepatitis C tests in 2023.
-
Which are the leading players in the Hepatitis C tests market?
The key companies in the Hepatitis C tests market are Abbott Laboratories, Grifols SA, F. Hoffmann-La Roche Ltd, QuidelOrtho Corp, Hologic Inc, Oswaldo Cruz Foundation, Siemens AG, Qiagen NV and DiaSorin SpA among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.